Table 2.

Impact of gender on PWV in healthy and hypertensive patients

	Healthy normotensive group	Hypertensive group
Male (<50 y)	5.85 ± 1.1 (3.1‐9.8) n = 265	7.2 ± 1.4 (5.1‐10.9) n = 84 **
Male (≥50 y)	8.4 ± 1.4 (5.5‐13.4) n = 146 *	8.8 ± 2.0 (5.6‐15.7) n = 95 *
Female (<50 y)	6.0 ± 0.9 (3.2‐9.1) n = 222	7.1 ± 1.3 (4.5‐11.2) n = 69 **
Female (≥50 y)	8.1 ± 1.1 (5.4‐12.3) n = 147 *	8.6 ± 1.5 (5.7‐14.5) n = 51 *,**

PWV [m/s] ± SD (range) of healthy and hypertensive patients, according to gender and age subgroups. Statistical significance assessed using the ANOVA test: *P < .001 with respect to patients under 50 y of age. Statistical significance assessed using the Student's t test: **P < .01 with respect to the normotensive group.